These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 14986084

  • 1. The post-transplant lymphoproliferative disorder-a literature review.
    Shroff R, Rees L.
    Pediatr Nephrol; 2004 Apr; 19(4):369-77. PubMed ID: 14986084
    [Abstract] [Full Text] [Related]

  • 2. Surveillance of Epstein-Barr virus infection as a risk factor for post-transplant lymphoproliferative disorder in pediatric renal transplant recipients.
    Köpf S, Tönshoff B.
    Pediatr Nephrol; 2004 Apr; 19(4):365-8. PubMed ID: 14963763
    [Abstract] [Full Text] [Related]

  • 3. [Post-transplant lymphoproliferative disorders in renal transplantation: two decades of experience].
    Franco A, Jiménez L, Sillero C, Trigueros M, González D, Alcaraz E, Olivares J.
    Nefrologia; 2010 Apr; 30(6):669-75. PubMed ID: 21113217
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.
    San-Juan R, Comoli P, Caillard S, Moulin B, Hirsch HH, Meylan P, ESCMID Study Group of Infection in Compromised Hosts.
    Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():109-18. PubMed ID: 24475976
    [Abstract] [Full Text] [Related]

  • 5. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
    Hosseini-Moghaddam SM, Alhomayeed B, Soliman N, Weir MA, House AA.
    Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725
    [Abstract] [Full Text] [Related]

  • 6. The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder.
    Martinez OM, Krams SM.
    Transplantation; 2017 Sep; 101(9):2009-2016. PubMed ID: 28376031
    [Abstract] [Full Text] [Related]

  • 7. Epstein Barr viral load monitoring by quantitative PCR in renal transplant patients.
    Merlino C, Cavallo R, Bergallo M, Giacchino F, Bollero C, Negro Ponzi A, Cavallo G.
    New Microbiol; 2003 Apr; 26(2):141-9. PubMed ID: 12737195
    [Abstract] [Full Text] [Related]

  • 8. Initial spontaneous remission of posttransplantation Epstein Barr virus-related B-cell lymphoproliferative disorder of the skin in a renal transplant recipient: case report and review of the literature on cutaneous B-cell posttransplantation lymphoproliferative disease.
    Blokx WA, Andriessen MP, van Hamersvelt HW, van Krieken JH.
    Am J Dermatopathol; 2002 Oct; 24(5):414-22. PubMed ID: 12357204
    [Abstract] [Full Text] [Related]

  • 9. Posttransplant lymphoproliferative disorder in pediatric renal transplantation.
    Srivastava T, Zwick DL, Rothberg PG, Warady BA.
    Pediatr Nephrol; 1999 Nov; 13(9):748-54. PubMed ID: 10603113
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease.
    Burns DM, Crawford DH.
    Blood Rev; 2004 Sep; 18(3):193-209. PubMed ID: 15183903
    [Abstract] [Full Text] [Related]

  • 11. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 12. Induction of pre-transplant Epstein-Barr virus (EBV) infection by donor blood transfusion in EBV-seronegative recipients may reduce risk of post-transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases.
    Babel N, Gabdrakhmanova L, Hammer M, Rosenberger C, Oppert M, Volk HD, Reinke P.
    Transpl Infect Dis; 2005 Jan; 7(3-4):133-6. PubMed ID: 16390402
    [Abstract] [Full Text] [Related]

  • 13. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
    Styczynski J, Gil L, Tridello G, Ljungman P, Donnelly JP, van der Velden W, Omar H, Martino R, Halkes C, Faraci M, Theunissen K, Kalwak K, Hubacek P, Sica S, Nozzoli C, Fagioli F, Matthes S, Diaz MA, Migliavacca M, Balduzzi A, Tomaszewska A, Camara Rde L, van Biezen A, Hoek J, Iacobelli S, Einsele H, Cesaro S, Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
    Clin Infect Dis; 2013 Sep; 57(6):794-802. PubMed ID: 23771985
    [Abstract] [Full Text] [Related]

  • 14. Epstein-Barr virus load in transplant patients: Early detection of post-transplant lymphoproliferative disorders.
    Fellner MD, Durand KA, Solernou V, Bosaleh A, Balbarrey Z, García de Dávila MT, Rodríguez M, Irazu L, Alonio LV, Picconi MA.
    Rev Argent Microbiol; 2016 Sep; 48(2):110-8. PubMed ID: 27157146
    [Abstract] [Full Text] [Related]

  • 15. Post-transplant Lymphoproliferative Disorder of Naso-orbital Region in Adult Renal Transplant Recipients: A Case Report and Literature Review.
    Nimitpanya P, Limpanavongsaen P, Udomkarnjananun S, Jutivorakool K, Vanichanan J.
    Transplant Proc; 2020 Nov; 52(9):2731-2735. PubMed ID: 32089317
    [Abstract] [Full Text] [Related]

  • 16. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G, Cantoni S, Oreste P, Klersy C, Gini G, Rossi V, D'Avanzo G, Comoli P, Baldanti F, Montillo M, Nosari A, Morra E, Cooperative Study Group on PTLDs.
    Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
    [Abstract] [Full Text] [Related]

  • 17. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
    Hart M, Thakral B, Yohe S, Balfour HH, Singh C, Spears M, McKenna RW.
    Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
    [Abstract] [Full Text] [Related]

  • 18. Primary Cutaneous Polymorphic EBV-Associated Posttransplant Lymphoproliferative Disorder After a Renal Transplant and Review of the Literature.
    Ferguson NN, Thomas CP, Hohl RJ, Syrbu SI, Stone MS, Wanat KA.
    Am J Dermatopathol; 2015 Oct; 37(10):790-4. PubMed ID: 25747810
    [Abstract] [Full Text] [Related]

  • 19. Asymptomatic post-transplant lymphoproliferative disorder diagnosed at one year protocol renal allograft biopsy.
    Kitajima K, Sasaki H, Koike J, Nakazawa R, Sato Y, Yazawa M, Tsuruoka K, Kawarazaki H, Imai N, Shirai S, Shibagaki Y, Chikaraishi T.
    Nephrology (Carlton); 2014 Jun; 19 Suppl 3():42-4. PubMed ID: 24842822
    [Abstract] [Full Text] [Related]

  • 20. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
    Franco A, Jiménez L, Aranda I, Alvarez L, González M, Rocamora N, Olivares J.
    Nefrologia; 2002 Jun; 22(5):463-9. PubMed ID: 12497748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.